BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35361921)

  • 1. DNA methylation signature associated with Bohring-Opitz syndrome: a new tool for functional classification of variants in ASXL genes.
    Awamleh Z; Chater-Diehl E; Choufani S; Wei E; Kianmahd RR; Yu A; Chad L; Costain G; Tan WH; Scherer SW; Arboleda VA; Russell BE; Weksberg R
    Eur J Hum Genet; 2022 Jun; 30(6):695-702. PubMed ID: 35361921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANKRD11 pathogenic variants and 16q24.3 microdeletions share an altered DNA methylation signature in patients with KBG syndrome.
    Awamleh Z; Choufani S; Cytrynbaum C; Alkuraya FS; Scherer S; Fernandes S; Rosas C; Louro P; Dias P; Neves MT; Sousa SB; Weksberg R
    Hum Mol Genet; 2023 Apr; 32(9):1429-1438. PubMed ID: 36440975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into DNA methylation signatures: SMARCA2 variants in Nicolaides-Baraitser syndrome.
    Chater-Diehl E; Ejaz R; Cytrynbaum C; Siu MT; Turinsky A; Choufani S; Goodman SJ; Abdul-Rahman O; Bedford M; Dorrani N; Engleman K; Flores-Daboub J; Genevieve D; Mendoza-Londono R; Meschino W; Perrin L; Safina N; Townshend S; Scherer SW; Anagnostou E; Piton A; Deardorff M; Brudno M; Chitayat D; Weksberg R
    BMC Med Genomics; 2019 Jul; 12(1):105. PubMed ID: 31288860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the phenotypic spectrum of ASXL-related disease: Ten cases and a review of the literature.
    Cuddapah VA; Dubbs HA; Adang L; Kugler SL; McCormick EM; Zolkipli-Cunningham Z; Ortiz-González XR; McCormack S; Zackai E; Licht DJ; Falk MJ; Marsh ED
    Am J Med Genet A; 2021 Jun; 185(6):1700-1711. PubMed ID: 33751773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new blood DNA methylation signature for Koolen-de Vries syndrome: Classification of missense KANSL1 variants and comparison to fibroblast cells.
    Awamleh Z; Choufani S; Wu W; Rots D; Dingemans AJM; Nadif Kasri N; Boronat S; Ibañez-Mico S; Cuesta Herraiz L; Ferrer I; Martínez Carrascal A; Pérez-Jurado LA; Aznar Lain G; Ortigoza-Escobar JD; de Vries BBA; Koolen DA; Weksberg R
    Eur J Hum Genet; 2024 Mar; 32(3):324-332. PubMed ID: 38282074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants.
    Siu MT; Butcher DT; Turinsky AL; Cytrynbaum C; Stavropoulos DJ; Walker S; Caluseriu O; Carter M; Lou Y; Nicolson R; Georgiades S; Szatmari P; Anagnostou E; Scherer SW; Choufani S; Brudno M; Weksberg R
    Clin Epigenetics; 2019 Jul; 11(1):103. PubMed ID: 31311581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the neurodevelopmental and motor phenotypes of Bohring-Opitz syndrome (ASXL1) and Bainbridge-Ropers syndrome (ASXL3).
    Ayoub MC; Anderson JT; Russell BE; Wilson RB
    Front Neurosci; 2023; 17():1244176. PubMed ID: 38027485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.
    Shashi V; Pena LD; Kim K; Burton B; Hempel M; Schoch K; Walkiewicz M; McLaughlin HM; Cho M; Stong N; Hickey SE; Shuss CM; ; Freemark MS; Bellet JS; Keels MA; Bonner MJ; El-Dairi M; Butler M; Kranz PG; Stumpel CT; Klinkenberg S; Oberndorff K; Alawi M; Santer R; Petrovski S; Kuismin O; Korpi-Heikkilä S; Pietilainen O; Aarno P; Kurki MI; Hoischen A; Need AC; Goldstein DB; Kortüm F
    Am J Hum Genet; 2016 Oct; 99(4):991-999. PubMed ID: 27693232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of CD96 and ASXL1 in 11 patients with Opitz C or Bohring-Opitz syndromes.
    Urreizti R; Roca-Ayats N; Trepat J; Garcia-Garcia F; Aleman A; Orteschi D; Marangi G; Neri G; Opitz JM; Dopazo J; Cormand B; Vilageliu L; Balcells S; Grinberg D
    Am J Med Genet A; 2016 Jan; 170A(1):24-31. PubMed ID: 26768331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and cancer genomics of ASXL family members.
    Katoh M
    Br J Cancer; 2013 Jul; 109(2):299-306. PubMed ID: 23736028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic ASXL1 somatic variants in reference databases complicate germline variant interpretation for Bohring-Opitz Syndrome.
    Carlston CM; O'Donnell-Luria AH; Underhill HR; Cummings BB; Weisburd B; Minikel EV; Birnbaum DP; ; Tvrdik T; MacArthur DG; Mao R
    Hum Mutat; 2017 May; 38(5):517-523. PubMed ID: 28229513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical findings in 39 individuals with Bohring-Opitz syndrome from a global patient-driven registry with implications for tumor surveillance and recurrence risk.
    Russell BE; Kianmahd RR; Munster C; Yu A; Ahad L; Tan WH
    Am J Med Genet A; 2023 Apr; 191(4):1050-1058. PubMed ID: 36751885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiomics of Bohring-Opitz syndrome truncating ASXL1 mutations identify canonical and noncanonical Wnt signaling dysregulation.
    Lin I; Wei A; Awamleh Z; Singh M; Ning A; Herrera A; ; Russell BE; Weksberg R; Arboleda VA
    JCI Insight; 2023 May; 8(10):. PubMed ID: 37053013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An HNRNPK-specific DNA methylation signature makes sense of missense variants and expands the phenotypic spectrum of Au-Kline syndrome.
    Choufani S; McNiven V; Cytrynbaum C; Jangjoo M; Adam MP; Bjornsson HT; Harris J; Dyment DA; Graham GE; Nezarati MM; Aul RB; Castiglioni C; Breckpot J; Devriendt K; Stewart H; Banos-Pinero B; Mehta S; Sandford R; Dunn C; Mathevet R; van Maldergem L; Piard J; Brischoux-Boucher E; Vitobello A; Faivre L; Bournez M; Tran-Mau F; Maystadt I; Fernández-Jaén A; Alvarez S; García-Prieto ID; Alkuraya FS; Alsaif HS; Rahbeeni Z; El-Akouri K; Al-Mureikhi M; Spillmann RC; Shashi V; Sanchez-Lara PA; Graham JM; Roberts A; Chorin O; Evrony GD; Kraatari-Tiri M; Dudding-Byth T; Richardson A; Hunt D; Hamilton L; Dyack S; Mendelsohn BA; Rodríguez N; Sánchez-Martínez R; Tenorio-Castaño J; Nevado J; Lapunzina P; Tirado P; Carminho Amaro Rodrigues MT; Quteineh L; Innes AM; Kline AD; Au PYB; Weksberg R
    Am J Hum Genet; 2022 Oct; 109(10):1867-1884. PubMed ID: 36130591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of DNA Methylation Signatures and Classification of Variants in Rare Neurodevelopmental Disorders Using EpigenCentral.
    Awamleh Z; Goodman S; Kallurkar P; Wu W; Lu K; Choufani S; Turinsky AL; Weksberg R
    Curr Protoc; 2022 Nov; 2(11):e597. PubMed ID: 36367395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel splicing mutation in the ASXL3 gene causing Bainbridge-Ropers syndrome.
    Hori I; Miya F; Ohashi K; Negishi Y; Hattori A; Ando N; Okamoto N; Kato M; Tsunoda T; Yamasaki M; Kanemura Y; Kosaki K; Saitoh S
    Am J Med Genet A; 2016 Jul; 170(7):1863-7. PubMed ID: 27075689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional Sex Combs-like Family Associated with Epigenetic Regulation.
    Kim N; Byun S; Um SJ
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bohring-Opitz syndrome caused by an ASXL1 mutation inherited from a germline mosaic mother.
    Bedoukian E; Copenheaver D; Bale S; Deardorff M
    Am J Med Genet A; 2018 May; 176(5):1249-1252. PubMed ID: 29681100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.
    Katoh M
    Expert Rev Proteomics; 2015 Jun; 12(3):317-28. PubMed ID: 25835095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASXL gain-of-function truncation mutants: defective and dysregulated forms of a natural ribosomal frameshifting product?
    Dinan AM; Atkins JF; Firth AE
    Biol Direct; 2017 Oct; 12(1):24. PubMed ID: 29037253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.